Franklin Resources
ELDN icon

Franklin Resources’s Eledon Pharmaceuticals ELDN Stock Holding History

Franklin Resources’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,936
Closed -$2.62M – 1499
2016
Q2 		$2.62M Hold
2,936
– – ﹤0.01% 1216
2016
Q1 		$2.67M Hold
2,936
– – ﹤0.01% 1209
2015
Q4 		$4.15M Buy
2,936
+148
+5% +$258K ﹤0.01% 1167
2015
Q3 		$4.67M Hold
2,788
– – ﹤0.01% 1157
2015
Q2 		$6.01M Hold
2,788
– – ﹤0.01% 1144
2015
Q1 		$5.1M Buy
2,788
+52
+2% +$115K ﹤0.01% 1173
2014
Q4 		$6.53M Buy
2,736
+267
+11% +$634K ﹤0.01% 1131
2014
Q3 		$6.06M Buy
+2,469
New +$7.02M ﹤0.01% 1150

Other funds holding ELDN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EA
Emerald Acquisition Seattle, Washington $51.8B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources's ELDN Position: Q3 2016 in Review

Franklin Resources sold out of Eledon Pharmaceuticals (ELDN) in Q3 2016, closing a stake of 2,936 shares — an estimated $2.62M sold.

Franklin Resources first reported a position in ELDN in Q3 2014 and held it in 8 quarters. The position peaked at $6.53M in Q4 2014. 44 funds tracked by Wall St. Rank hold ELDN as of Q3 2016.

  • Franklin Resources reported no remaining Eledon Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Franklin Resources sold 2,936 Eledon Pharmaceuticals shares in Q3 2016, an estimated $2.62M.
  • Franklin Resources first reported a position in Eledon Pharmaceuticals in Q3 2014 and held it in 8 quarters.
  • Franklin Resources's Eledon Pharmaceuticals position peaked at $6.53M in Q4 2014.
  • 44 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2016.

Based on Franklin Resources's 13F filing for Q3 2016, filed 14 Nov 2016.